Back to Search
Start Over
1P Sitravatinib + tislelizumab in patients with anti-PD-(L)1 refractory/resistant metastatic non-small cell lung cancer (NSCLC).
- Source :
-
Annals of Oncology . 2022 Supplement 1, Vol. 33, pS1-S1. 1p. - Publication Year :
- 2022
- Subjects :
- *NON-small-cell lung carcinoma
*METASTASIS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 155492216
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.01.063